Health Condition 1: null- Healthy Volunteers and in subjects with mild Asthma or COPD
Conditions
Interventions
Intervention1: Revolizer (Dry Powder Inhaler): Investigational Device: Revolizer with placebo rotacaps. Usage of placebo rotacap was depend upon the number of attempts required by the subject.
Control
Sponsors
Cipla Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects and healthy volunteers willing to sign informed consent 2. Subjects and healthy volunteers of 18 years and above 3. Subjects with or without a respiratory condition. Each subject with a respiratory condition (prior experience of using an inhaler) should be matched as far as possible with an individual without a respiratory condition (inhaler naïve) with respect to the age, sex, literacy status etc 4. Subjects with mild Asthma or COPD
Exclusion criteria
Exclusion criteria: 1. Subjects already using Dry Powder Inhaler (DPI) prior to start of the study. 2. Subjects with co-ordination problems like Parkinson?s disease, mental illness, tremors etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Average time taken for three consecutive correct attempts during the first and second visit.Timepoint: First and Second Visit | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Type and number of errors during first and second visit. 2.Confidence assessment 3.Usability assessment 4.Preference assessment and 5.Satisfaction assessmentTimepoint: First and Second Visit | — |
Countries
India
Contacts
Public ContactDr Pramod Niphadkar
Cipla Ltd.
Outcome results
None listed